Pharmaceutical Lipid-Based Excipients Industry Revenue to Reach $2.29 Billion by 2030 with CAGR of 5.3% (2026-2030)


 The Business Research Company’s 2026 market reports introduce new features such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, all designed to enhance the depth, usability, and strategic value of the insights provided.

What Is the Forecasted Market Size of the Pharmaceutical Lipid-Based Excipients Market by 2030?
The pharmaceutical lipid-based excipients market size has grown strongly in recent years. It will grow from $1.77 billion in 2025 to $1.86 billion in 2026 at a compound annual growth rate (CAGR) of 5.2%. The growth in the historic period can be attributed to growth in poorly water-soluble drug pipelines, advancements in lipid formulation science, expansion of pharmaceutical manufacturing, rising use of oral delivery systems, regulatory support for lipid excipients.

The pharmaceutical lipid-based excipients market size is expected to see strong growth in the next few years. It will grow to $2.29 billion in 2030 at a compound annual growth rate (CAGR) of 5.3%. The growth in the forecast period can be attributed to growth in complex drug formulations, increasing demand for enhanced drug absorption, expansion of biologics and oncology drugs, advancements in lipid technologies, rising focus on patient-centric formulations. Major trends in the forecast period include increasing use of lipid excipients for poorly soluble drugs, growing adoption in oral and parenteral formulations, rising demand for bioavailability-enhancing excipients, expansion of lipid-based drug delivery systems, increasing focus on natural and sustainable lipids.

Claim your free report sample now:
https://www.thebusinessresearchcompany.com/report/pharmaceutical-lipid-based-excipients-global-market-report

What Are the Key Drivers of the Pharmaceutical Lipid-Based Excipients Market?
The rise in gene therapy is expected to propel the growth of the pharmaceutical lipid-based excipients market going forward. Gene therapy is a medical technique that involves modifying or manipulating a person's genes to treat or prevent disease. The rise in gene therapy is due to advancements in delivery systems, as they enable safe, efficient, and targeted transport of genetic material into cells. Pharmaceutical lipid-based excipients enhance gene therapy by enabling efficient delivery systems, ensuring stability and targeted transport of genetic material. They improve therapeutic outcomes by protecting nucleic acids and facilitating cellular uptake, advancing the effectiveness of modern treatments. For instance, in December 2024, according to American Society of Gene & Cell Therapy (ASGCT), a US-based non-profit medical and scientific organization, the Food and Drug Administration (FDA) approved 6 gene therapy products in 2023, up from five approvals in 2022. Therefore, the rise in gene therapy is driving the growth of the pharmaceutical lipid-based excipients market.

What Segments Are Covered in the Pharmaceutical Lipid-Based Excipients Market Report?
The pharmaceutical lipid-based excipients market covered in this report is segmented –

1) By Excipient Type: Oils, Hydrogenated Vegetable Oils, GMCC, Hard Fats, Medium Chain Triglycerides, Lecithin And Phospholipids, Sodium Oleate, Capri Caprylic Mono Diglyceride, Other Excipient Types
2) By Product Applications: Oral Formulations, Parenteral, Topical Applications, Ophthalmic Applications, Suppositories, Other Product Applications
3) By Disease Application: Cardiovascular Diseases, Neurological Disorders, Oncology, Metabolic Disorders, Hormonal Therapies, Infectious Diseases, Other Disease Applications
4) By Age Group: Pediatric Products (0-18 years), Adult Products (19-64 years), Geriatric Products (65+ years)
5) By End-Use: Pharmaceutical Manufacturers, Contract Development And Manufacturing Organizations, Other End Users

Subsegments:
1) By Oils: Soybean Oil, Olive Oil, Palm Oil, Sunflower Oil, Other Oils
2) By Hydrogenated Vegetable Oils: Hydrogenated Soybean Oil, Hydrogenated Palm Oil, Hydrogenated Cottonseed Oil, Other Hydrogenated Vegetable Oils
3) By GMCC (Glyceryl Mono/Diesters of C16/C18): Glyceryl Monostearate, Glyceryl Distearate, Glyceryl Monopalmitate, Other GMCC
4) By Hard Fats: Hydrogenated Castor Oil, Hydrogenated Palm Kernel Oil, Hydrogenated Coconut Oil, Other Hard Fats
5) By Medium Chain Triglycerides (MCTs): Capric Triglycerides, Caprylic Triglycerides, Caprylic-Capric Triglycerides, Other MCTs
6) By Lecithin and Phospholipids: Soy Lecithin, Egg Lecithin, Phosphatidylcholine, Phosphatidylserine, Other Lecithin and Phospholipids
7) By Sodium Oleate: Pharmaceutical Grade Sodium Oleate, Food Grade Sodium Oleate, Industrial Grade Sodium Oleate
8) By Capri-Caprylic Mono/Diglycerides: Capric-Caprylic Monoglycerides, Capric-Caprylic Diglycerides
9) By Other Excipient Types: Sucrose Esters, Fatty Acid Esters, PEGylated Lipids, Other Miscellaneous Lipids

What Are the Most Prominent Trends Impacting the Pharmaceutical Lipid-Based Excipients Market?
Major companies operating in the pharmaceutical lipid-based excipients market are focusing on investments such as a strategic investment to develop an advanced Center of Excellence to drive innovation, enhance formulation capabilities, support drug delivery research, and strengthen their competitive position in emerging therapeutic areas. For instance, in November 2024, Gattefossé SAS, a France-based chemical manufacturing company, opened a cutting-edge Technical Center of Excellence in Mumbai to support India's growing pharma market, offering specialized labs and tailored support for excipient innovation, with a focus on bioavailability, sustained release, and topical formulations, while strengthening its presence in the Asia-Pacific region. The state-of-the-art facility encompasses pharmaceutical and personal care application laboratories to foster innovation, encourage collaboration, and provide a productive work environment.

What Are the Top Companies to Watch in the Pharmaceutical Lipid-Based Excipients Market?
Major companies operating in the pharmaceutical lipid-based excipients market are Cargill Incorporated, BASF SE, Merck KGaA, FUJIFILM Corporation, Evonik Industries AG, DuPont de Nemours Inc., Stepan Company, Croda International, Ashland Corporation, NOF CORPORATION, CordenPharma, SEPPIC, Nippon Fine Chemical Co. Ltd., Cayman Chemical, ABITEC Corporation, Creative Biolabs, IOI Oleo GmbH, Lipoid, RuixiBiotechCo.Ltd, Biosynth

Get the full pharmaceutical lipid-based excipients market report here:
https://www.thebusinessresearchcompany.com/report/pharmaceutical-lipid-based-excipients-global-market-report

Which Region Is Expected to Lead the Pharmaceutical Lipid-Based Excipients Market by 2030?
Europe was the largest region in the pharmaceutical lipid-based excipients market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmaceutical lipid-based excipients market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Contact Us:

The Business Research Company: Global Market Research Reports & Consulting | The Business Research Company
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: info@tbrc.info

Follow Us On:

LinkedIn: The Business Research Company | LinkedIn

Comments

Post a Comment

Popular posts from this blog

Train And Components Market Report 2025 – Strategic Data for Growth and Expansion

Image
  Unlock 30% off global market reports with code ONLINE30 – get insights on tariff changes, macro trends, and global economic shifts. What is the anticipated market size of the train and components industry over the next few years? The train and components market size has grown strongly in recent years. It will grow from $245.66 billion in 2024 to $266.59 billion in 2025 at a compound annual growth rate (CAGR) of 8.5%. The growth in the historic period can be attributed to economic conditions, urbanization, government investment, environmental concerns. The train and components market size is expected to see strong growth in the next few years. It will grow to $354.13 billion in 2029 at a compound annual growth rate (CAGR) of 7.4%. The growth in the forecast period can be attributed to high-speed rail expansion, sustainable transport, electrification, freight rail expansion, regulatory compliance. Major trends in the forecast period include electrification and lightweighting, advan...
Read more

Global Fire Retardant Welding Blanket Market Report 2025: Market Opportunities & Challenges Outlook

Image
  For organizations targeting expansion, this report delivers actionable intelligence on how the fire retardant welding blanket industry is evolving. How Big Is The Fire Retardant Welding Blanket Market In 2025? The fire retardant welding blanket market size has grown strongly in recent years. It will grow from $1.22 billion in 2024 to $1.32 billion in 2025 at a compound annual growth rate (CAGR) of 8.1%. The growth in the historic period can be attributed to rising use of asbestos alternatives in thermal protection, growing deployment of welding blankets in shipbuilding, increasing fire incidents in manufacturing facilities, rising preference for reusable fire safety equipment, and growing reliance on manual welding techniques. The fire retardant welding blanket market size is expected to see strong growth in the next few years. It will grow to $1.77 billion in 2029 at a compound annual growth rate (CAGR) of 7.7%. The growth in the forecast period can be attributed to increasing a...
Read more

Construction Market Outlook 2025 – In-Depth Data for Business Expansion to 2034

Image
Unlock 30% off global market reports with code ONLINE30 – get insights on tariff changes, macro trends, and global economic shifts What is the current market size of the construction industry, and what growth rate is it expected to achieve? The construction market size has grown strongly in recent years. It will grow from $16152.39 billion in 2024 to $17045.95 billion in 2025 at a compound annual growth rate (CAGR) of 5.5%. The growth in the historic period can be attributed to the increasing infrastructure development, the increase in renovation activities, rapid growth in the elderly population, and the rise in domestic manufacturing. The construction market size is expected to see strong growth in the next few years. It will grow to $21260.28 billion in 2029 at a compound annual growth rate (CAGR) of 5.7%. The growth in the forecast period can be attributed to rising urbanization, increasing population growth, increasing government support, rising industrialization, and an increase ...
Read more